Immunogenetics of pregnancy: Role of a 14-bp deletion in the maternal HLA-G gene in primiparous pre-eclamptic Brazilian women

Human Immunology

Volumn 68, Issue 8, 2007, Pages 668-674

  Vianna, Priscila ^a   Dalmáz, Caroline Abrão ^a,b   Veit, Tiago Degani ^a   Tedoldi, Citânia ^c   Roisenberg, Israel ^a   Chies, José Artur Bogo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Mestrado em Avaliação de Impactos Ambientais em Mineração   (Brazil)

^c HOSPITAL NOSSA SENHORA DA CONCEIÇÃO   (Brazil)

Author keywords

HLA G polymorphism; Immunomodulation; Pre eclampsia

Indexed keywords

HLA G ANTIGEN;

3' UNTRANSLATED REGION; ADULT; ALLELE; ANTIGEN EXPRESSION; ARTICLE; BASE PAIRING; BRAZIL; CONTROLLED STUDY; EXON; FEMALE; FETOPLACENTAL UNIT; GENE; GENE DELETION; GENOTYPE; HLA G GENE; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; PATHOGENESIS; PREECLAMPSIA; PRIMIPARA; PRIORITY JOURNAL; TROPHOBLAST;

ADULT; BRAZIL; FEMALE; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IMMUNOGENETICS; PARITY; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; SEQUENCE DELETION;

EID: 34547158659     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2007.05.006     Document Type: Article

References (56)

1. Pregnancy WGRoHBPi. Report of the National high Blood Pressure Education Program. Am J Obstet Gynecol 183 (2000) S1
2. Dekker G., and Sibai B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 357 (2001) 209
3. Vatten L.J., and Skjaerven R. Is pre-eclampsia more than one disease?. Br J Obstet Gynaecol 111 (2004) 298
4. Haukkamaa L., Salminen M., Laivuori H., Leinonen H., Hiilesmaa V., and Kaaja R. Risk for subsequent coronary artery disease after preeclampsia. Am J Cardiol 93 (2004) 805
5. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 (2003) 181
6. Hauth J.C., Ewell M.G., Levine R.J., Esterlitz J.R., Sibai B., Curet L.B., Catalano P.M., Morris C.D., and Calcium for Preeclampsia Prevention Study Group. Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol 95 (2000) 24
7. Zhang J., Meikle S., and Trumble A. Severe maternal morbidity associated with hypertensive disorders in pregnancy in the United States. Hypertens Pregnancy 22 (2003) 203
8. Marzi M., Vigano A., Trabattoni D., Villa M.L., Salvaggio A., Clerici E., and Clerici M. Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 106 (1996) 127
9. Raghupathy R. Th1-type immunity is incompatible with successful pregnancy. Immunol Today 18 (1997) 478
10. Reinhard G., Noll A., Schlebusch H., Mallmann P., and Ruecker A.V. Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 245 (1998) 933
11. Saito S., Umekage H., Sakamoto Y., Sakai M., Tanebe K., Sasaki Y., and Morikawa H. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol 41 (1999) 297
12. Wilczynski J.R. Th1/Th2 cytokines balance-yin and yang of reproductive immunology. Eur J Obstet Gynecol Reprod Biol 122 (2005) 136
13. Crisa L., McMaster M.T., Ishii J.K., Fisher S.J., and Salomon D.R. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts. J Exp Med 186 (1997) 289
14. Feger U., Tolosa E., Huang Y.H., Waschbisch A., Biedermann T., Melms A., and Wiendl H. HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation (2007) Blood First Edition Paper, prepublished online March 19, DOI 10.1182/blood-2006-11-057125
15. Rebmann V., Busemann A., Lindemann M., and Grosse-Wilde H. Detection of HLA-G5 secreting cells. Hum Immunol 64 (2003) 1017
16. Hofmeister V., and Weiss E.H. HLA-G modulates immune responses by diverse receptor interactions. Semin Cancer Biol 13 (2003) 317
17. Le Gal F.A., Riteau B., Sedlik C., Khalil-Daher I., Menier C., Dausset J., et al. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol 11 (1999) 1351
18. Riteau B., Rouas-Freiss N., Menier C., Paul P., Dausset J., and Carosella E.D. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 166 (2001) 5018
19. Rouas-Freiss N., Goncalves R.M., Menier C., Dausset J., and Carosella E.D. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 94 (1997) 11520
20. Moreau P., Adrian-Cabestre F., Menier C., Guiard V., Gourand L., Dausset J., et al. IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 11 (1999) 803
21. LeMaoult J., Caumartin J., Daouya M., Favier B., Le Rond S., Gonzalez A., and Carosella E.D. Immune regulation by pretenders: Cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109 (2007) 2040
22. Fanchin R., Gallot V., Rouas-Freiss N., Frydman R., and Carosella E.D. Implication of HLA-G in Human Embryo Implantation. Hum Immunol 68 (2007) 259
23. Ellis S.A., Palmer M.S., and McMichael A.J. Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol 144 (1990) 731
24. Fujii T., Ishitani A., and Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J Immunol 153 (1994) 5516
25. Harrison G.A., Humphrey K.E., Jakobsen I.B., and Cooper D.W. A 14 bp deletion polymorphism in the HLA-G gene. Hum Mol Genet 2 (1993) 2200
26. Hviid T.V., Hylenius S., Rorbye C., and Nielsen L.G. HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55 (2003) 63
27. Hviid T.V., Rizzo R., Christiansen O.B., Melchiorri L., Lindhard A., and Baricordi O.R. HLA-G and IL-10 in serum in relation to HLA-G genotype and polymorphisms. Immunogenetics 56 (2004) 135
28. Ishitani A., Kishida M., Sageshima N., Yashiki S., Sonoda S., Hayami M., et al. Re-examination of HLA-G polymorphism in African Americans. Immunogenetics 49 (1999) 808
29. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., and Geraghty D.E. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J Immunol 171 (2003) 1376
30. Kovats S., Main E.K., Librach C., Stubblebine M., Fisher S.J., and DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 248 (1990) 220
31. Le Bouteiller P., Pizzato N., Barakonyi A., and Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J Reprod Immunol 59 (2003) 219
32. Yamashita T., Fujii T., Watanabe Y., Tokunaga K., Tadokoro K., Juji T., and Taketani Y. HLA-G gene polymorphism in a Japanese population. Immunogenetics 44 (1996) 186
33. Hiby S.E., King A., Sharkey A., and Loke Y.W. Molecular studies of trophoblast HLA-G: Polymorphism, isoforms, imprinting and expression in preimplantation embryo. Tissue Antigens 53 (1999) 1
34. Rousseau P., Le Discorde M., Mouillot G., Marcou C., Carosella E.D., and Moreau P. The 14 bp deletion-insertion polymorphism in the 3′ UT region of the HLA-G gene influences HLA-G mRNA stability. Hum Immunol 64 (2003) 1005
35. Tripathi P., Abbas A., Naik S., and Agrawal S. Role of 14-bp deletion in the HLA-G gene in the maintenance of pregnancy. Tissue Antigens 64 (2004) 706
36. Hviid T.V. HLA-G in human reproduction: Aspects of genetics, function and pregnancy complications. Hum Reprod Update 12 (2006) 209
37. Rebmann V., van der Ven K., Passler M., Pfeiffer K., Krebs D., and Grosse-Wilde H. Association of soluble HLA-G plasma levels with HLA-G alleles. Tissue Antigens 57 (2001) 15
38. Yie S.M., Taylor R.N., and Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am J Obstet Gynecol 193 (2005) 204
39. Yao Y.Q., Barlow D.H., and Sargent I.L. Differential expression of alternatively spliced transcripts of HLA-G in human preimplantation embryos and inner cell masses. J Immunol 175 (2005) 8379
40. Menezo Y., Elder K., and Viville S. Soluble HLA-G release by the human embryo: An interesting artefact?. Reprod Biomed Online 13 (2006) 763
41. Brown M.A., Hague W.M., Higgins J., Lowe S., McCowan L., Oats J., et al. The detection, investigation and management of hypertension in pregnancy: Executive summary. Aust N Z J Obstet Gynaecol 40 (2000) 133
42. Sibai B., Dekker G., and Kupferminc M. Pre-eclampsia. Lancet 365 (2005) 785
43. Lahiri D.K., and Nurnberger Jr. J.I. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res 19 (1991) 5444
44. Chaouat G., Ledee-Bataille N., Dubanchet S., Zourbas S., Sandra O., and Martal J. TH1/TH2 paradigm in pregnancy: Paradigm lost?. Cytokines in pregnancy/early abortion: Reexamining the TH1/TH2 paradigm. Int Arch Allergy Immunol 134 (2004) 93
45. Wegmann T.G., Lin H., Guilbert L., and Mosmann T.R. Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?. Immunol Today 14 (1993) 353
46. Goldman-Wohl D.S., Ariel I., Greenfield C., Hochner-Celnikier D., Cross J., Fisher S., and Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod 6 (2000) 88
47. Hara N., Fujii T., Yamashita T., Kozuma S., Okai T., and Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: Immunohistological demonstration with anti-HLA-G specific antibody "87G" and anti-cytokeratin antibody "CAM5.2". Am J Reprod Immunol 36 (1996) 349
48. Lim K.J., Odukoya O.A., Li T.C., and Cooke I.D. Cytokines and immuno-endocrine factors in recurrent miscarriage. Hum Reprod Update 2 (1996) 469
49. Hylenius S., Andersen A.M., Melbye M., and Hviid T.V. Association between HLA-G genotype and risk of pre-eclampsia: A case-control study using family triads. Mol Hum Reprod 10 (2004) 237
50. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., and Moreau P. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: Possible role of the HLA-G gene in susceptibility to the disease. Cell Mol Life Sci 58 (2001) 1943
51. Einarsson J.I., Sangi-Haghpeykar H., and Gardner M.O. Sperm exposure and development of preeclampsia. Am J Obstet Gynecol 188 (2003) 1241
52. Robillard P.Y., Hulsey T.C., Perianin J., Janky E., Miri E.H., and Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 344 (1994) 973
53. Dekker G., and Robillard P.Y. The birth interval hypothesis-does it really indicate the end of the primipaternity hypothesis. J Reprod Immunol 59 (2003) 245
54. Saftlas A.F., Levine R.J., Klebanoff M.A., Martz K.L., Ewell M.G., Morris C.D., and Sibai B.M. Abortion, changed paternity, and risk of preeclampsia in nulliparous women. Am J Epidemiol 157 (2003) 1108
55. Hviid T.V., Hylenius S., Hoegh A.M., Kruse C., and Christiansen O.B. HLA-G polymorphisms in couples with recurrent spontaneous abortions. Tissue Antigens 60 (2002) 122
56. Hviid T.V., Moller C., Sorensen S., and Morling N. Co-dominant expression of the HLA-G gene and various forms of alternatively spliced HLA-G mRNA in human first trimester trophoblast. Hum Immunol 59 (1998) 87